This is the authors' abstract. We don't add key points for this paper.
Recently, both native and recombinant preparations of human osteopontin (OPN) have been shown to be able to induce the production of several proinflammatory cytokines in human peripheral blood mononuclear cells (PBMCs) or purified monocytes. In the present study, we found that commercially available native and recombinant OPNs contain variable amounts of endotoxin (LPS) and that removal of endotoxin by polymyxin B-agarose column abrogated their cytokine-inducing activity. These results suggest the questionable evidence of the ability of OPN to induce several cytokines in human PBMCs and draw attention to the exquisite sensitivity of PBMCs/monocytes to endotoxin contaminants.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Konno et al. (2005) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: